Providers Medicare’s Push To Improve Chronic Care Attracts Businesses, but Not Many Doctors By Phil Galewitz and Holly K. Hacker, KFF Health News
BioPharma, Pharma, Legal AstraZeneca Loses Lawsuit Challenging Drug Price Negotiation by Medicare By Frank Vinluan
MedCity Influencers Resources, Industry Support Will Help Primary Care Practices Meet Increased Medicare Demand for CGM By Dr. Lucienne Marie Ide
MedCity Influencers Does Chronic Disease Management in Medicare Advantage Need a ‘Retail’ Makeover? By Tony Vahedian
Consumer / Employer, Legal, Physicians AMA President: Medicare Physician Pay Cuts Will Have ‘Dire’ Impact if Not Reversed By Marissa Plescia
MedCity Influencers, Payers Will We Close the Medicare Advantage Primary Care Gap in 2024? By Jim Bonnette
Daily, MedCity Influencers, Patient Engagement Leveraging Personalized Digital Engagement to Elevate Medicare Advantage Star Ratings By Carrie Kozlowski
Consumer / Employer, Payers Report: The Average Medicare Beneficiary Will Choose From 43 MA Plans in 2024 By Marissa Plescia
Health Tech, Pharma Why One Expert Thinks the Medicare Drug Price Negotiation Program Is Here to Stay By Katie Adams
Consumer / Employer, Payers Study: MA Beneficiaries Have Lower Utilization Than Traditional Medicare By Marissa Plescia
Consumer / Employer, Payers Report: 7 Ways Medicare Advantage Is Being Marketed on TV By Marissa Plescia